| Literature DB >> 35736175 |
Hengtong Zhang1, Xixi Wu1, Liang Quan1, Qiang Ao1.
Abstract
Oceans have vast potential to develop high-value bioactive substances and biomaterials. In the past decades, many biomaterials have come from marine organisms, but due to the wide variety of organisms living in the oceans, the great diversity of marine-derived materials remains explored. The marine biomaterials that have been found and studied have excellent biological activity, unique chemical structure, good biocompatibility, low toxicity, and suitable degradation, and can be used as attractive tissue material engineering and regenerative medicine applications. In this review, we give an overview of the extraction and processing methods and chemical and biological characteristics of common marine polysaccharides and proteins. This review also briefly explains their important applications in anticancer, antiviral, drug delivery, tissue engineering, and other fields.Entities:
Keywords: biomedical applications; collagen; extraction methods; marine biomaterials; marine polysaccharides; tissue engineering
Mesh:
Substances:
Year: 2022 PMID: 35736175 PMCID: PMC9228671 DOI: 10.3390/md20060372
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1(a) Chitin recovery by chemical and biological methods [12]. (b) Structural formula of chitin and chitosan. (c) An instance of chitosan modification [18].
Figure 2Stylized conformation structures of alginate units, blocks, and their linkages M unit: β-d-mannuronic acid residue; G unit: α-l-guluronic acid residues. Alginates are extracted and purified from various brown algae and have the gelation ability.
Figure 3(a) Chemical structures of idealized repeating units of carrageenan; (b) two types of fucoidan backbones. R is the potential attachment of carbohydrate (α-l-fucopyranose and α-d-glucuronicacid) and non-carbohydrate (sulfate and acetyl groups) substituents; (c) structure of the major repeating disaccharide units that comprise ulvan; (d) schematic illustration of laminarin structure and its derivatives.
Figure 4Repeating disaccharide units of different GAGs. CS chains are constituted of d-glucuronic (GlcA) and N-acetylgalactosamine (GalNAc) residues. DS is a stereoisomer of CS, including l-iduronic acid (IdoA) instead of or in addition to GlcA [76]. KS is composed of different combinations of repeating units of d-galactose (Gal) and GlcNAc [76]. HS chains comprise GlcA and d-glucosamine (GlcN). Heparin chains comprise IdoA and GlcN. These sugar residues can be esterified by sulfate at various positions as indicated by “X” or “Y” enclosed by a circle [79].
Figure 5Collagen structure and the sequential amino acid contents along with the structure, and obtaining gelatin from collagen denatured by thermal and chemical treatment.
Summary of collagen isolated from marine organisms.
| Collagen Type | Source | Extraction Solvent or Method | Yield (Y) | Refs |
|---|---|---|---|---|
| Collagen type I | Tilapia Scales | A combination of dilute acetic acid (0.1 M and 0.5 M) with ultrafine bubbles | Y = 1.58% | [ |
| Collagen type I | Chinese sturgeon (Acipenser sturio Linnaeus) skins | 2.42% pepsin solution | The maximum yield of 86.69% | [ |
| Collagen | Carp scale | 300 mg/g of pepsin solution, 0.3 mol/L acetic acid solution, and 200 min ultrasonic | Y = 28.7% | [ |
| Collagen type I | Scales of | 0.5 M AcOH | nearly 5% | [ |
| Collagen type I and II | Skin and notochord of Bester sturgeon | M NaOH | Y (type I) = 63.9 ± 0.19% | [ |
| Collagen/gelatin | Sponge samples of the species | High-pressure carbon dioxide-acidified water | nearly 50% | [ |
| Collagen type I and V | Tiger puffer | 0.5 M AcOH and 1:20–1:50 ( | / | [ |
| Collagen type I and V | Trash fish, leather jacket ( | 0.5 mol/L AcOH and 0.1% ( | Y = 64–71% | [ |
| Collagen type II | Cartilages of skate and sturgeon | 0.5 mol/L AcOH containing 0.1% ( | / | [ |
| Collagen type III | Jellyfish ( | 0.5 M AcOH (1:100 | Y (jellyfish bell) = 37.08% | [ |
Figure 6Carrageenan may be used to specifically target the viral attachment of SARS-CoV-2. The figure is reprinted from Ref. [50] with permission from the publisher.
Figure 7Interrelations of marine origin polysaccharides in drug delivery systems for advanced therapies and applications. The figure is reprinted from Ref. [138] with permission from the publisher.
Figure 8Schematic showing the wide range of applications for marine biomaterial.
Biomaterials from marine organisms applied in tissue engineering.
| Materials | Marine Biomaterial Sources | Testing Cell Source or Active Ingredient | Forming Method | Application | Advantages (A) and Disadvantages (D) | Ref. |
|---|---|---|---|---|---|---|
| Alginate/gelation/ECM | Brown algae | Human HepaRG liver cells | Extrusion 3D printing | Liver tissue engineering | A: Improved cell viability and hepatic metabolic activity; high precision and stability of the printed constructs; | [ |
| Collagen | jellyfish | Human and rat chondrocytes | Freeze-drying | Cartilage tissue | A: Safe, no cytotoxic effects, biocompatible, | [ |
| Carrageenan/PVA | Red algae | Mesenchymal stem cells | Freeze-drying | Cartilage tissue | A: Cell viability and the increase in proliferation; | [ |
| Alginate/gelatin | Brown algae | 10T1/2 and HAE cells | Enzyme-catalyzed | Fabrication of cell sheets and spherical tissues | A: Shorter time for enclosed cell growth; enhanced cell adhesion; maintaining on-demand degradability | [ |
| CS/CHS/PDLLA | Shell | NGF | Layer-by-layer and Electro-Static-assembly technique | Neural tissue | A: Good mechanical properties and degradation properties; good biocompatibility with Schwann cells | [ |
| Alginate/gelation | Brown algae | hMSCs | micro-extrusion 3D printing | Bone tissue engineering | A: Provided uniform macropores and different compressive moduli | [ |
| CHS/hydroxyapatite | Shell | MC3T3-E1 | Extrusion 3D printing | Bone tissue engineering | A: Good mechanical support after printing and provided highly active cell-platforms | [ |
| SF/CS/HA | / | L929 | Freeze-drying | Dermal tissue engineering | A: Contributed to blood capillary network formation; stimulated repair cells to secrete and enrich growth factors | [ |
| Collagen/CHS | Blue shark ( | 6T-CEM and hFOB12 | Freeze-drying | Bone tissue engineering | A: Compact, regular pore shapes; good biocompatibility and osteogenesis properties | [ |
| Chitin | hBMSCs and human dermal MSCs | Decellularization and demineralization | Tissue engineering | A: Simplicity and ease of the isolation; interconnected porosity; excellent biocompatibility; | [ | |
| CHS/collagen | Shell/salmon skins | MSCs | Freeze-drying | Bone and cartilage tissue engineering | A: Enhanced the mechanical properties; enhances both MSC osteogenesis and chondrogenesis. | [ |
| Collagen | Shark Skin | Chondrocyte cells (ATDC5) | Freeze-drying, Supercritical | Cartilage tissue engineering | A: Highly porous and interconnected; Allows the cell adhesion, growth, and proliferation | [ |
| Alginate/gelation | Brown algae | L929 and smooth muscle cells | 3D printing | Vessel tissue engineering | A: Structures with multilevel fluidic channels; sufficient mechanical strength; exhibits biocompatibility | [ |
| Collagen/PLLA | Fish | Intestinal organoids | Solvent casting | Intestine tissue engineering | A: Beneficial in trapping the seeded cells, enhanced cell viability and growth, biofunctionality | [ |
| PCL/collagen | Fish-Scale | corneal endothelial cells | Cross-linked | Ocular tissue engineering | A: Suitable spherical curvature, transparent and biocompatible | [ |
| Alginate | Brown algae | ZnO NPs | Ionic cross-linked | Dermal tissue engineering | A: Durable antibacterial; allows accessible mobility of molecular exchange required for improving chronic wound healing | [ |
| Alginate/Gelatin | Brown algae | human dental pulp stem cells (hDPSCs) | 3D printing | Dental tissue engineering | A: Suitable for the growth of hDPSCs; promoted cell proliferation and differentiation | [ |
| collagen | Salmon | HUVEC | Chemical cross-linked | Vessel tissue engineering | A: Biodegradability; enhanced the production of inflammatory cytokines in HUVECs | [ |
| HS | Mollusk | / | Enzymatic Treatments | Anticoagulant drug | A: Inhibited thrombus growth in photochemically injured arteries | [ |
| Collagen/PLGA | Tilapia skin | / | Self-assembly; electrospinning | Tissue engineering | A: Good biocompatibility and immunogenicity; good hemostatic function; guided bone regeneration | [ |
Figure 9(A) Immunofluorescence detection of representative chondrogenic-related markers, SOX-9 and ACAN under basal and chondrogenic conditions after 21 days of culture on the Coll and Coll: Hya structures (Scale bar: 50 μm). (B) Representative microscopic observation of the repaired tissues at 3 and 6 months postoperatively. Red circles indicate the defect area. (C) ICRS score for macroscopic assessment. Data are presented as the mean ± SD (n = 8). (D) Antibacterial activity of TiO2 nanoparticles and scaffolds. ((A) was reproduced from Ref. [170] with permission from the publisher; (B,C) were reproduced from Ref. [171] with permission from the publisher; (D) was reproduced from Ref. [174] with permission from the publisher).